Linked from

The 26 pages that link to Myasthenia gravis, each with the reason it gives.

• AcetylcholineRelated: The disease weakens muscles by reducing their response to acetylcholine.

• Neuromuscular junctionRelated: Reduced receptor function weakens the muscle response to nerve signals.

• ElectromyographyRelated: Specialized EMG methods can detect impaired neuromuscular transmission.

• DysphagiaRelated: Fatigable weakness can involve muscles used for chewing and swallowing.

• Synaptic transmissionRelated: It shows how postsynaptic disruption can weaken transmission to muscle.

• ThymusRelated: Thymic abnormalities, including thymoma, are associated with this autoimmune disease.

• Acetylcholinesterase inhibitorRelated: Acetylcholinesterase inhibitors can improve muscle strength by prolonging acetylcholine action.

• AzathioprineRelated: Its slower immunosuppressive effect can help control disease and reduce glucocorticoid requirements.

• Plasma exchangeRelated: Exchange can temporarily lower pathogenic antibodies during severe worsening or before selected procedures.

• Bernard KatzRelated: Katz’s synaptic framework helps distinguish reduced transmitter release from impaired postsynaptic response.

• PlasmapheresisRelated: Plasma exchange can rapidly reduce disease-causing antibodies during severe exacerbations.

• Synaptic cleftRelated: Antibodies commonly reduce postsynaptic acetylcholine receptors across the cleft.

• NeostigmineRelated: Neostigmine can improve muscle strength by increasing acetylcholine at the neuromuscular junction.